Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Geiser

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 4, 2008
Combined determination of the chemical composition and of health effects of secondary organic aerosols: the POLYSOA projectUrs Baltensperger, Josef Dommen, M Rami Alfarra, et al.
Frontiers in Toxicology|July 14, 2022
A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip SystemArunima Sengupta, Nuria Roldan, Mirjam Kiener, et al.
Respiration; International Review of Thoracic Diseases|December 25, 2022
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung StudyAlexandra Lenoir, Andreas Christe, Lukas Ebner, et al.
Respiration; International Review of Thoracic Diseases|August 14, 2014
The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohortsNebal Abu Hussein, Gerben Ter Riet, Lucia Schoenenberger, et al.
Respiration; International Review of Thoracic Diseases|February 10, 2015
Long-term data from the Swiss pulmonary hypertension registrySéverine Mueller-Mottet, Hans Stricker, Guido Domenighetti, et al.
Respiration; International Review of Thoracic Diseases|July 19, 2017
Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD AuditMichael Buess, Daniel Schilter, Tino Schneider, et al.
Respiration; International Review of Thoracic Diseases|August 24, 2018
Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018Daiana Stolz, Jürg Barandun, Heinz Borer, et al.
Health and Quality of Life Outcomes|December 20, 2024
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPREDRoy Meys, Frits M E Franssen, Alex J Van 't Hul, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2020
Urinary Leukotriene E<sub>4</sub> and Prostaglandin D<sub>2</sub> Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational StudyJohan Kolmert, Cristina Gómez, David Balgoma, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthmaPaul Brinkman, Ariane H Wagener, Pieter-Paul Hekking, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 4, 2008
Combined determination of the chemical composition and of health effects of secondary organic aerosols: the POLYSOA projectUrs Baltensperger, Josef Dommen, M Rami Alfarra, et al.
Frontiers in Toxicology|July 14, 2022
A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip SystemArunima Sengupta, Nuria Roldan, Mirjam Kiener, et al.
Respiration; International Review of Thoracic Diseases|December 25, 2022
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung StudyAlexandra Lenoir, Andreas Christe, Lukas Ebner, et al.
Respiration; International Review of Thoracic Diseases|August 14, 2014
The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohortsNebal Abu Hussein, Gerben Ter Riet, Lucia Schoenenberger, et al.
Respiration; International Review of Thoracic Diseases|February 10, 2015
Long-term data from the Swiss pulmonary hypertension registrySéverine Mueller-Mottet, Hans Stricker, Guido Domenighetti, et al.
Respiration; International Review of Thoracic Diseases|July 19, 2017
Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD AuditMichael Buess, Daniel Schilter, Tino Schneider, et al.
Respiration; International Review of Thoracic Diseases|August 24, 2018
Diagnosis, Prevention and Treatment of Stable COPD and Acute Exacerbations of COPD: The Swiss Recommendations 2018Daiana Stolz, Jürg Barandun, Heinz Borer, et al.
Health and Quality of Life Outcomes|December 20, 2024
Clinical importance of patient-reported outcome measures in severe asthma: results from U-BIOPREDRoy Meys, Frits M E Franssen, Alex J Van 't Hul, et al.
American Journal of Respiratory and Critical Care Medicine|July 16, 2020
Urinary Leukotriene E<sub>4</sub> and Prostaglandin D<sub>2</sub> Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational StudyJohan Kolmert, Cristina Gómez, David Balgoma, et al.
The Journal of Allergy and Clinical Immunology|December 12, 2018
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthmaPaul Brinkman, Ariane H Wagener, Pieter-Paul Hekking, et al.
Pageof 14